Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Achard

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|January 17, 2009
Telmisartan for prevention of cardiovascular eventsRoxana Oprisiu Fournier, Jean-Michel Achard, Albert Fournier
Journal of Vascular Research|October 29, 2005
Vasoconstrictive effect of angiotensin IV in isolated rat basilar artery independent of AT1 and AT2 receptorsSebastien Faure, James Javellaud, Jean-Michel Achard, et al.
Advances in Chronic Kidney Disease|April 4, 2006
Inherited sodium avid statesJean-Michel Achard, Juliette Hadchouel, Sébastien Faure, et al.
Journal of the American College of Cardiology|April 20, 2004
Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trialsAlbert Fournier, Franz H Messerli, Jean Michel Achard, et al.
Lancet (London, England)|December 14, 2002
The OPTIMMAL trial: losartan or captopril after acute myocardial infarctionAlbert Fournier, Michel Andrejak, Michel Slama, et al.
JAMA|February 15, 2003
Losartan vs atenolol in prevention of stroke and cardiovascular diseaseAlbert Fournier, Roxana Oprisiu, Michel Andrejak, et al.
Journal of Hypertension|March 19, 2005
VALUE and supremacy of blood pressure control for cardiovascular protectionAlbert Fournier, Janet Mansour, Hakim Mazouz, et al.
Journal of the American Society of Nephrology : JASN|October 14, 2005
Familial hyperkalemic hypertensionJuliette Hadchouel, Céline Delaloy, Sébastien Fauré, et al.
Lancet (London, England)|December 7, 2007
The JIKEI trialFlorent Boutitie, François Gueyffier, Jean-Michel Achard, et al.
Lancet (London, England)|November 25, 2003
The CHARM programmeJeanette Mansour, Marcel Peltier, Roxana Oprisiu, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|January 17, 2009
Telmisartan for prevention of cardiovascular eventsRoxana Oprisiu Fournier, Jean-Michel Achard, Albert Fournier
Journal of Vascular Research|October 29, 2005
Vasoconstrictive effect of angiotensin IV in isolated rat basilar artery independent of AT1 and AT2 receptorsSebastien Faure, James Javellaud, Jean-Michel Achard, et al.
Advances in Chronic Kidney Disease|April 4, 2006
Inherited sodium avid statesJean-Michel Achard, Juliette Hadchouel, Sébastien Faure, et al.
Journal of the American College of Cardiology|April 20, 2004
Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trialsAlbert Fournier, Franz H Messerli, Jean Michel Achard, et al.
Lancet (London, England)|December 14, 2002
The OPTIMMAL trial: losartan or captopril after acute myocardial infarctionAlbert Fournier, Michel Andrejak, Michel Slama, et al.
JAMA|February 15, 2003
Losartan vs atenolol in prevention of stroke and cardiovascular diseaseAlbert Fournier, Roxana Oprisiu, Michel Andrejak, et al.
Journal of Hypertension|March 19, 2005
VALUE and supremacy of blood pressure control for cardiovascular protectionAlbert Fournier, Janet Mansour, Hakim Mazouz, et al.
Journal of the American Society of Nephrology : JASN|October 14, 2005
Familial hyperkalemic hypertensionJuliette Hadchouel, Céline Delaloy, Sébastien Fauré, et al.
Lancet (London, England)|December 7, 2007
The JIKEI trialFlorent Boutitie, François Gueyffier, Jean-Michel Achard, et al.
Lancet (London, England)|November 25, 2003
The CHARM programmeJeanette Mansour, Marcel Peltier, Roxana Oprisiu, et al.
Pageof 4